37 results on '"Atalar, Arife Çimen"'
Search Results
2. Clinical Pictures and Diagnostic Features of COVID-19 Headache
- Author
-
Atalar, Arife Çimen, Baykan, Betül, Martelletti, Paolo, Series Editor, Özge, Aynur, editor, Uludüz, Derya, editor, Bolay, Hayrunnisa, editor, and Karadaş, Ömer, editor
- Published
- 2023
- Full Text
- View/download PDF
3. Exploring shared triggers and potential etiopathogenesis between migraine and idiopathic/genetic epilepsy: Insights from a multicenter tertiary-based study
- Author
-
Yapıcı, Zuhal, Midi, İpek, Saygı, Serap, Çelebi, Ulufer, Darol, Elif Sarıca, Ağan, Kadriye, Ayça, Senem, Gazioğlu, Sibel, Okudan, Zeynep Vildan, Şirin, Nermin Görkem, Bebek, Nerses, Dericioğlu, Neşe, Altun, İlknur Güçlü, Yalçın, Ayşe Destina, Sürmeli, Reyhan, Erdinç, Oğuz Osman, Erdal, Abidin, Algın, Demet İlhan, Kutlu, Gülnihal, Bek, Semai, Erdal, Yüksel, Özön, Akçay Övünç, Reyhani, Aylin, Güldiken, Babürhan, Baklan, Barış, Genç, Bülent Oğuz, Altındağ, Ebru Aykutlu, Karahan, Gökçen, Koç, Güray, Mısırlı, Handan, Öztura, İbrahim, Aslan-Kara, Kezban, Çakar, Merve Melodi, Türkmen, Nur, Bulut, Onur, Karadaş, Ömer, Şahin, Özlem Kesim, Ferik, Sevgi, Peköz, Mehmet Taylan, Topaloğlu, Pınar, Özek, Sibel Üstün, Düzgün, Ülkühan, Yayla, Vildan, Gömceli, Yasemin, Acar, Zeynep Ünlüsoy, Türk, Bengi Gül, Yeni, Seher Naz, Atalar, Arife Çimen, Ekizoğlu, Esme, Gök, Duygu Kurt, Baykan, Betül, Özge, Aynur, Ayta, Semih, Erdoğan, Füsun Ferda, Taşdelen, Bahar, and Velioğlu, Sibel K.
- Published
- 2024
- Full Text
- View/download PDF
4. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study
- Author
-
Abbariao, Maritoni, Zaki, Shafiq Dexter Abou, Aleksic, Dejan, Aliling, Nicole, Rivas, Susana Arias, Artajos, Godard, Asukile, Melody, Atalar, Arife Çimen, Bae, Jong Seok, Banzrai, Chimeglkham, Bar, Michal, Barone, Valentina, Baykan, Betul, Beghi, Ettore, Berger, Thomas, Bilic, Ivica, Biller, Jose, Boskovic, Mateja, Cabreira, Verónica, Calado, Sofia, Canete, Maria Teresa, Celebisoy, Nese, Chen, Ike Leon, Chishimba, Lorraine, Chomba, Mashina, Constantino, Glenn Anthony, Cotelli, Maria Sofia, De Cauwer, Harald, Debroucker, Thomas, Orantes, Luis Del Carpio, Devaraj, Rashmi, D'Souza, Michelle, Ekizoglu, Esme, Elmali, Ayse Deniz, Fonseca, Ana Catarina, Furloni, Roberto, Gajre, Sunil, Azorin, David Garcia, Garfoot, Vanessa, Gasparic, Irena, Genç, Hamit, Glavica, Marinka, Guanaes, Luiz Gustavo, Gürsoy, Gizem, Hafiz, Nauman, Hasırcı, Buse, Helbok, Raimund, Hor, Chee Peng, Hughes, Stella, Hwang, Sungeun, Kaya, Irem Ilgezdi, Jakupi, Adi, Jamora, Roland Dominic, Kahwagi, Jamil, Kaprelyan, Ara, Kawatu, Nfwama, Kim, Manho, Kim, Hyunji, Kim, Hyun Kyung, Koffie, Desmond, Ladeira, Filipa, Lant, Suzannah, Lee, Woo-Jin, Lee, Sukyoon, Leonardo, Zerlyn, Lim, Christian Emmanuel, Lisak, Marijana, Loh, Hong Chuan, Loo, Lay Khoon, Huzjan, Arijana Lovrencic, Koh, Rosie Sue Luan Lu, Luabeya, Mesu'a Kabwa, Lugaresi, Alessandra, Macrohon, Bernadette, Majdak, Maja, Manalili, Sheryl, Manelli, Filippo, Mapoure, Yacouba Njankouo, Mascarella, Davide, Massano, João, Mataa, Mataa, Matibag, Jessica Leika, Matic-Gerodias, Alexandria, McMullen, Kate, Miranda, Miguel, Modequillo, Margaret, Shoab, Abul Kalam Mohammed, Motto, Cristina, Murphy, Sinead M., Mwendaweli, Naluca, Ng, Chen Fei, Ng, Rong Xiang, Ihsan, Mohd Khairul Nizam Nor, Nyein, Aye Myat, O'Connell, Karen, Oh, Seong-il, Ohnmar, Ohnmar, Özge, Aynur, Pajo, Azalea, Palavra, Filipe, Panteleienko, Larysa, Payne, Catherine, Pensato, Umberto, Peres, João, Peters, Steven, Polat, Burcu, Poljakovic, Zdravka, Punter, Martin Nicholas Michael, Quiles, Liz Edenberg, Ranieri, Angelo, Ratković, Marija, Renales, Maria Lina, Robles, Jose, Bedeković, Marina Roje, Rommer, Paulus, Šapina, Lidija, Sarac, Helena, Saylor, Deanna, Schmutzhard, Erich, Sharma, Anahita, Šimić, Aleksandra, Sipilä, Jussi O.T., Sokhi, Dilraj, Stagno, Mauro, Stancheva, Kristina, Stojsavljević, Marija, Subir, Ahamed, Surdhar, Sushee, Talabucon, Loreto, Jr, Tan, Hui Jan, Teoh, Sing Chiek, Vallejo, Dionis, Velioglu, Sibel K., Vukasović, Rafaela, Kit, Wong Wai, Welte, Tamara, Willekens, Barbara, Yesilot, Nilufer, Yu, Jeryl Ritzi T., Zaw, Moe Moe, Zhelyazkova, Sashka, Žitnik, Eva, Tamborska, A.A., Wood, G.K., Westenberg, E., Garcia-Azorin, D., Webb, G., Schiess, N., Netravathi, M., Baykan, B., Dervaj, R., Helbok, R., Lant, S., Özge, A., Padovani, A., Saylor, D., Schmutzhard, E., Easton, A., Lilleker, J.B., Jackson, T., Beghi, E., Ellul, M.A., Frontera, J.A., Pollak, T., Nicholson, T.R., Wood, N., Thakur, K.T., Solomon, T., Stark, R.J., Winkler, A.S., and Michael, B.D.
- Published
- 2023
- Full Text
- View/download PDF
5. Predictors of successful valproate withdrawal in women with epilepsy
- Author
-
Atalar, Arife Çimen, Şirin, Nermin Görkem, Bebek, Nerses, and Baykan, Betül
- Published
- 2021
- Full Text
- View/download PDF
6. Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.
- Author
-
Sebastianelli, Gabriele, Atalar, Arife Çimen, Cetta, Ilaria, Farham, Fatemeh, Fitzek, Mira, Karatas-Kursun, Hulya, Kholodova, Marharyta, Kukumägi, Kadri-Hebo, Montisano, Danilo Antonio, Onan, Dilara, Pantovic, Aleksandar, Skarlet, Jeva, Sotnikov, Dmytro, Caronna, Edoardo, and Pozo-Rosich, Patricia
- Subjects
- *
SLEEP deprivation , *MIGRAINE , *DATABASES , *HYPOTHALAMUS , *PRODROMAL symptoms - Abstract
Background: The prodrome or premonitory phase is the initial phase of a migraine attack, and it is considered as a symptomatic phase in which prodromal symptoms may occur. There is evidence that attacks start 24–48 hours before the headache phase. Individuals with migraine also report several potential triggers for their attacks, which may be mistaken for premonitory symptoms and hinder migraine research. Methods: This review aims to summarize published studies that describe contributions to understanding the fine difference between prodromal/premonitory symptoms and triggers, give insights for research, and propose a way forward to study these phenomena. We finally aim to formulate a theory to unify migraine triggers and prodromal symptoms. For this purpose, a comprehensive narrative review of the published literature on clinical, neurophysiological and imaging evidence on migraine prodromal symptoms and triggers was conducted using the PubMed database. Results: Brain activity and network connectivity changes occur during the prodromal phase. These changes give rise to prodromal/premonitory symptoms in some individuals, which may be falsely interpreted as triggers at the same time as representing the early manifestation of the beginning of the attack. By contrast, certain migraine triggers, such as stress, hormone changes or sleep deprivation, acting as a catalyst in reducing the migraine threshold, might facilitate these changes and increase the chances of a migraine attack. Migraine triggers and prodromal/premonitory symptoms can be confused and have an intertwined relationship with the hypothalamus as the central hub for integrating external and internal body signals. Conclusions: Differentiating migraine triggers and prodromal symptoms is crucial for shedding light on migraine pathophysiology and improve migraine management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Reflex epileptic features in patients with focal epilepsy of unknown cause
- Author
-
Atalar, Arife Çimen, Vanlı-Yavuz, Ebru Nur, Yılmaz, Ebru, Bebek, Nerses, and Baykan, Betül
- Published
- 2020
- Full Text
- View/download PDF
8. Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics
- Author
-
Atalar, Arife Çimen, Vanlı-Yavuz, Ebru Nur, Yılmaz, Ebru, Bebek, Nerses, and Baykan, Betül
- Published
- 2020
- Full Text
- View/download PDF
9. Exploring shared triggers and potential etiopathogenesis between migraine and idiopathic/genetic epilepsy: Insights from a multicenter tertiary-based study
- Author
-
Türk, Bengi Gül, primary, Yeni, Seher Naz, additional, Atalar, Arife Çimen, additional, Ekizoğlu, Esme, additional, Gök, Duygu Kurt, additional, Baykan, Betül, additional, Özge, Aynur, additional, Ayta, Semih, additional, Erdoğan, Füsun Ferda, additional, Taşdelen, Bahar, additional, Velioğlu, Sibel K., additional, Yapıcı, Zuhal, additional, Midi, İpek, additional, Saygı, Serap, additional, Çelebi, Ulufer, additional, Darol, Elif Sarıca, additional, Ağan, Kadriye, additional, Ayça, Senem, additional, Gazioğlu, Sibel, additional, Okudan, Zeynep Vildan, additional, Şirin, Nermin Görkem, additional, Bebek, Nerses, additional, Dericioğlu, Neşe, additional, Altun, İlknur Güçlü, additional, Yalçın, Ayşe Destina, additional, Sürmeli, Reyhan, additional, Erdinç, Oğuz Osman, additional, Erdal, Abidin, additional, Algın, Demet İlhan, additional, Kutlu, Gülnihal, additional, Bek, Semai, additional, Erdal, Yüksel, additional, Özön, Akçay Övünç, additional, Reyhani, Aylin, additional, Güldiken, Babürhan, additional, Baklan, Barış, additional, Genç, Bülent Oğuz, additional, Altındağ, Ebru Aykutlu, additional, Karahan, Gökçen, additional, Koç, Güray, additional, Mısırlı, Handan, additional, Öztura, İbrahim, additional, Aslan-Kara, Kezban, additional, Çakar, Merve Melodi, additional, Türkmen, Nur, additional, Bulut, Onur, additional, Karadaş, Ömer, additional, Şahin, Özlem Kesim, additional, Ferik, Sevgi, additional, Peköz, Mehmet Taylan, additional, Topaloğlu, Pınar, additional, Özek, Sibel Üstün, additional, Düzgün, Ülkühan, additional, Yayla, Vildan, additional, Gömceli, Yasemin, additional, and Acar, Zeynep Ünlüsoy, additional
- Published
- 2024
- Full Text
- View/download PDF
10. Reliability and Validity Study of the Migraine Interictal Burden Scale-4 in Turkish.
- Author
-
Karaci, Rahsan, Sünbül, Esra Aydin, Dikmen, Pinar Yalinay, Aydinlar, Elif Ilgaz, Bilgiç, Fehmi, Öksüz, Nevra, Özçelik, Emel Ur, Atalar, Arife Çimen, Tasdelen, Semih, Ekizoglu, Esme, Uludüz, Ezgi, Uludüz, Derya, Özge, Aynur, and Domaç, Füsun Mayda
- Published
- 2024
- Full Text
- View/download PDF
11. Olfactory dysfunction in multiple sclerosis
- Author
-
Atalar, Arife Çimen, Erdal, Yüksel, Tekin, Betül, Yıldız, Muhammed, Akdoğan, Özlem, and Emre, Ufuk
- Published
- 2018
- Full Text
- View/download PDF
12. One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases
- Author
-
Özge, Aynur, primary, Domaç, Füsun Mayda, additional, Tekin, Nil, additional, Sünbül, Esra Aydın, additional, Öksüz, Nevra, additional, Atalar, Arife Çimen, additional, Çallı, Sümeyye Yasemin, additional, Fidan, Yağmur Sever, additional, Evlice, Ahmet, additional, Beştepe, Engin Emrem, additional, İzci, Filiz, additional, Küsbeci, Özge Yılmaz, additional, Demirel, Esra Acıman, additional, Velioğlu, Sibel K., additional, and Ungan, Mehmet, additional
- Published
- 2023
- Full Text
- View/download PDF
13. Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis.
- Author
-
Giussani, Giorgia, Westenberg, Erica, Garcia-Azorin, David, Bianchi, Elisa, Yusof Khan, Abdul Hanif Khan, Allegri, Ricardo Francisco, Atalar, Arife Çimen, Baykan, Betul, Crivelli, Lucia, Fornari, Arianna, Frontera, Jennifer A., Guekht, Alla, Helbok, Raimund, Hoo, Fan Kee, Kivipelto, Miia, Leonardi, Matilde, Lopez Rocha, Ana Sabsil, Mangialasche, Francesca, Marcassoli, Alessia, and Özdag Acarli, Ayse Nur
- Subjects
NEUROLOGIC manifestations of general diseases ,NEUROMUSCULAR diseases ,NEUROLOGICAL disorders ,SLEEP disorders ,COVID-19 pandemic ,VASCULAR dementia ,MOVEMENT disorders - Abstract
Introduction: The aim of this systematic review and meta-analysis was to evaluate the prevalence of thirteen neurological manifestations in people affected by COVID-19 during the acute phase and at 3, 6, 9 and 12-month follow-up time points. Methods: The study protocol was registered with PROSPERO (CRD42022325505). MEDLINE (PubMed), Embase, and the Cochrane Library were used as information sources. Eligible studies included original articles of cohort studies, case-control studies, cross-sectional studies, and case series with ≥5 subjects that reported the prevalence and type of neurological manifestations, with a minimum follow-up of 3 months after the acute phase of COVID-19 disease. Two independent reviewers screened studies from January 1, 2020, to June 16, 2022. The following manifestations were assessed: neuromuscular disorders, encephalopathy/altered mental status/delirium, movement disorders, dysautonomia, cerebrovascular disorders, cognitive impairment/dementia, sleep disorders, seizures, syncope/transient loss of consciousness, fatigue, gait disturbances, anosmia/hyposmia, and headache. The pooled prevalence and their 95% confidence intervals were calculated at the six pre-specified times. Results: 126 of 6,565 screened studies fulfilled the eligibility criteria, accounting for 1,542,300 subjects with COVID-19 disease. Of these, four studies only reported data on neurological conditions other than the 13 selected. The neurological disorders with the highest pooled prevalence estimates (per 100 subjects) during the acute phase of COVID-19 were anosmia/hyposmia, fatigue, headache, encephalopathy, cognitive impairment, and cerebrovascular disease. At 3-month follow-up, the pooled prevalence of fatigue, cognitive impairment, and sleep disorders was still 20% and higher. At six- and 9-month follow-up, there was a tendency for fatigue, cognitive impairment, sleep disorders, anosmia/hyposmia, and headache to further increase in prevalence. At 12-month follow-up, prevalence estimates decreased but remained high for some disorders, such as fatigue and anosmia/hyposmia. Other neurological disorders had a more fluctuating occurrence. Discussion: Neurological manifestations were prevalent during the acute phase of COVID-19 and over the 1-year follow-up period, with the highest overall prevalence estimates for fatigue, cognitive impairment, sleep disorders, anosmia/hyposmia, and headache. There was a downward trend over time, suggesting that neurological manifestations in the early post-COVID-19 phase may be long-lasting but not permanent. However, especially for the 12-month follow-up time point, more robust data are needed to confirm this trend. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Diagnosis of comorbid migraine without aura in patients with idiopathic/genetic epilepsy based on the gray zone approach to the International Classification of Headache Disorders 3 criteria
- Author
-
Atalar, Arife Çimen, Özge, Aynur, Türk, Bengi Gül, Ekizoğlu, Esme, Kurt Gök, Duygu, Baykan, Betül, Ayta, Semih, Erdoğan, Füsun Ferda, Yeni, Seher Naz, Taşdelen, Bahar, and Velioğlu, Sibel K.
- Subjects
Neurology ,Neurology (clinical) - Abstract
BackgroundMigraine without aura (MwoA) is a very frequent and remarkable comorbidity in patients with idiopathic/genetic epilepsy (I/GE). Frequently in clinical practice, diagnosis of MwoA may be challenging despite the guidance of current diagnostic criteria of the International Classification of Headache Disorders 3 (ICHD-3). In this study, we aimed to disclose the diagnostic gaps in the diagnosis of comorbid MwoA, using a zone concept, in patients with I/GEs with headaches who were diagnosed by an experienced headache expert.MethodsIn this multicenter study including 809 consecutive patients with a diagnosis of I/GE with or without headache, 163 patients who were diagnosed by an experienced headache expert as having a comorbid MwoA were reevaluated. Eligible patients were divided into three subgroups, namely, full diagnosis, zone I, and zone II according to their status of fulfilling the ICHD-3 criteria. A Classification and Regression Tree (CART) analysis was performed to bring out the meaningful predictors when evaluating patients with I/GEs for MwoA comorbidity, using the variables that were significant in the univariate analysis.ResultsLonger headache duration (n = 62) in the CART analysis were 48.39% Juvenile myoclonic epilepsy followed by 25.81% epilepsy with generalized tonic-clonic seizures alone.ConclusionLonger headache duration, throbbing pain, increase of pain by physical activity, photophobia and/or phonophobia, presence of vertigo/dizziness, osmophobia, and higher VAS scores are the main supportive associated factors when applying the ICHD-3 criteria for the comorbid MwoA diagnosis in patients with I/GEs. Evaluating these characteristics could be helpful to close the diagnostic gaps in everyday clinical practice and fasten the diagnostic process of comorbid MwoA in patients with I/GEs.
- Published
- 2023
- Full Text
- View/download PDF
15. Correction to: Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics
- Author
-
Atalar, Arife Çimen, Vanlı-Yavuz, Ebru Nur, Yılmaz, Ebru, Bebek, Nerses, and Baykan, Betül
- Published
- 2020
- Full Text
- View/download PDF
16. Headache in idiopathic/genetic epilepsy: Cluster analysis in a large cohort
- Author
-
Atalar, Arife Çimen, primary, Türk, Bengi Gül, additional, Ekizoglu, Esme, additional, Kurt Gök, Duygu, additional, Baykan, Betül, additional, Özge, Aynur, additional, Ayta, Semih, additional, Erdoğan, Füsun Ferda, additional, Yeni, Seher Naz, additional, Taşdelen, Bahar, additional, Velioglu, Sibel K., additional, Yapıcı, Zuhal, additional, Midi, İpek, additional, Saygı, Serap, additional, Çelebi, Ulufer, additional, Sarıca Darol, Elif, additional, Ağan, Kadriye, additional, Ayça, Senem, additional, Gazioğlu, Sibel, additional, Okudan, Zeynep Vildan, additional, Şirin, Nermin Görkem, additional, Bebek, Nerses, additional, Dericioğlu, Neşe, additional, Güçlü Altun, İlknur, additional, Yalçın, Ayşe Destina, additional, Sürmeli, Reyhan, additional, Erdinç, Oğuz Osman, additional, Erdal, Abidin, additional, İlhan Algın, Demet, additional, Kutlu, Gülnihal, additional, Bek, Semai, additional, Erdal, Yüksel, additional, Özön, Akçay Övünç, additional, Reyhani, Aylin, additional, Güldiken, Babürhan, additional, Baklan, Barış, additional, Genç, Bülent Oğuz, additional, Aykutlu Altındağ, Ebru, additional, Karahan, Gökçen, additional, Koç, Güray, additional, Mısırlı, Handan, additional, Öztura, İbrahim, additional, Aslan‐Kara, Kezban, additional, Çakar, Merve Melodi, additional, Türkmen, Nur, additional, Bulut, Onur, additional, Karadaş, Ömer, additional, Kesim Şahin, Özlem, additional, Ferik, Sevgi, additional, Peköz, Mehmet Taylan, additional, Topaloğlu, Pınar, additional, Üstün Özek, Sibel, additional, Düzgün, Ülkühan, additional, Yayla, Vildan, additional, Gömceli, Yasemin, additional, and Ünlüsoy Acar, Zeynep, additional
- Published
- 2022
- Full Text
- View/download PDF
17. The Prevalence Of Migraine Comorbidity In Idiopathic Epilepsy Syndromes: The Preliminary Results Of A Multıcenter Study Across Turkey
- Author
-
BEBEK, NERSES, YAPICI, Zuhal, SARICA VAROL, ELİF, Yalcin, Ayse Destina, SÜRMELİ, REYHAN, AĞAN YILDIRIM, KADRİYE, GÜÇLÜ ALTUN, İLKNUR, BAKLAN, BARIŞ, BULUT, ONUR, MİDİ, İPEK, GAZİOĞLU, SİBEL, ŞİRİN İNAN, NERMİN GÖRKEM, YAYLA, VİLDAN AYŞE, OKUDAN, ZEYNEP VİLDAN, ATALAR, ARİFE ÇİMEN, TÜRK, BENGİ GÜL, KURT GÖK, DUYGU, EKİZOĞLU TURGUT, ESME, BAYKAN, BETÜL, ÖZGE, AYNUR, AYTA, SEMİH, ERDOĞAN, FİSUN FERDA, YENİ, SEHER NAZ, VELİOĞLU, SİBEL K, ÖZTURA, İBRAHİM, TÜRKMEN, NUR, ÇAKAR, MERVE MELODİ, PEKÖZ, MEHMET TAYLAN, KARAHAN, GÖKÇEN, AYKUTLU ALTINDAĞ, EBRU, ERDİNÇ, OĞUZ OSMAN, ÇELEBİ, ULUFER, ÜSTÜN ÖZEK, SİBEL, and AYÇA, SENEM
- Published
- 2020
18. DIFFERENT PROGNOSTIC PATTERNS IN EPILEPSIES AND CONSIDERATIONS ABOUT THE DENOTATIONS OF ATYPICAL PATTERNS
- Author
-
Atalar, Arife Çimen, primary and Baykan, Betül, additional
- Published
- 2021
- Full Text
- View/download PDF
19. Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.
- Author
-
ATALAR, Arife Çimen and BAYKAN, Betül
- Subjects
- *
GENETICS of epilepsy , *ANTICONVULSANTS , *BIOMARKERS , *ELECTROENCEPHALOGRAPHY , *STATUS epilepticus , *INFANTILE spasms , *TEMPORAL lobe epilepsy , *EPILEPSY , *FEBRILE seizures , *DRUG resistance , *DISEASE relapse , *SYMPTOMS , *SEIZURES (Medicine) , *COMORBIDITY , *DISEASE remission - Abstract
Epilepsy is a dynamic and heterogeneous neurological disease, and in long-term studies on prognosis, classically 5 basic patterns (early remission, late remission, relapsing-remitting, worsening, and non- remitting) have been identified. The most frequent pattern was relapsing- remitting course, and factors such as the presence of genetic etiology, rare seizures at the beginning of epilepsy and the absence of psychiatric comorbid diseases were found to be related with this pattern as well as reaching 5 years of remission in the follow-ups. Anti-seizure drug resistance (ASD-R) and factors affecting the presence of this resistance (such as symptomatic etiology, abnormal electroencephalographic findings, having multiple seizure types together, status epilepticus and febrile seizure history) decrease the chance of remission, while idiopathic/genetic etiology, generalized epilepsy, and absence of comorbid diseases seem to be associated with achieving long-term remission. Apart from these basic course patterns, there are some patients with an "atypical prognosis" such as drug-resistant juvenile myoclonic epilepsy (JME), benign hippocampal sclerosis-related mesial temporal lobe epilepsy (HS-MTLE), and severe childhood epilepsy with centro-temporal spikes (CESTS), in which the pathophysiological mechanisms underlying these patterns have not been clarified despite the suggestions of various hypotheses. The presence of comorbid diseases such as hormonal factors (as in catamenial epilepsy), autoimmune processes, thyroid disorders and metabolic and psychiatric diseases may also cause an atypical prognostic pattern by affecting the course of the disease. In this review, our aim is to provide the clinician with an up-to-date and questioning perspective on the prognostic markers of epilepsy, by examining in detail some specific epilepsy syndromes that may show atypical prognosis as well as the general prognostic features of epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Could Serum Endocan Be a Vascular Endothelial Marker in Relapsing-Remitting Multiple Sclerosis?
- Author
-
Atalar, Arife Çimen, Köseoğlu, Mesrure, Yavuz, Nurettin, Erdal, Yüksel, Oğuz, Osman, and Emre, Ufuk
- Subjects
- *
MULTIPLE sclerosis , *BIOMARKERS , *C-reactive protein , *STATISTICS , *ENDOTHELIUM , *INFLAMMATION , *HEALTH outcome assessment , *MANN Whitney U Test , *COMPARATIVE studies , *GLYCOPROTEINS , *BLOOD sedimentation , *ENZYME-linked immunosorbent assay , *DESCRIPTIVE statistics , *CHI-squared test , *BLOOD cell count , *RECEIVER operating characteristic curves , *DATA analysis , *DATA analysis software , *LONGITUDINAL method , *MEDICAL needs assessment - Abstract
Objective: Multiple sclerosis (MS) is a chronic degenerative and inflammatory disease leading to axonal damage and demyelination in the central nervous system. Although the pathogenesis is still controversial, it is accepted that there is an immune-mediated inflammatory response. Endothelial cell specific molecule-1 (ESM-1) (endocan) is expressed by endothelial cells under the control of cytokines, and increases in inflammatory processes involving the vascular endothelium. In this study, we aimed to compare serum endocan levels along with other hematologic inflammatory markers [such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)] in patients with relapsing-remitting MS (RRMS) and healthy controls. We also aimed at investigating the role of vascular endothelial dysfunction in RRMS. Materials and Methods: We enrolled 64 patients with RRMS in the remission period, and 37 healthy controls in the study. We investigated hematologic parameters (ESR, CRP) and serum ESM-1 levels by enzyme-linked immunosorbent assay. Results were compared between two groups statistically. Results: The CRP and ESR had no significant difference between patients and controls (p=0.861 and p=0.76 respectively). Serum endocan levels of the patient group were significantly higher than the healthy controls (p=0.045). RRMS patients with or without treatment and comorbid diseases showed no significant difference in serum endocan levels (p=0.565 and p=0.169 respectively). The predictive value of endocan was 62.0%, cut-off value was 9124.7326 pg/l, sensitivity was 68.8%, and specificity was 54.1%. Conclusion: We demonstrated higher serum endocan levels in patients with RRMS in remission period, confirming the role of vascular inflammation. Further studies including larger patient cohorts are needed to support our results. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Correction to: Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics
- Author
-
Atalar, Arife Çimen, primary, Vanlı-Yavuz, Ebru Nur, additional, Yılmaz, Ebru, additional, Bebek, Nerses, additional, and Baykan, Betül, additional
- Published
- 2019
- Full Text
- View/download PDF
22. Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics
- Author
-
Atalar, Arife Çimen, primary, Vanlı-Yavuz, Ebru Nur, additional, Yılmaz, Ebru, additional, Bebek, Nerses, additional, and Baykan, Betül, additional
- Published
- 2019
- Full Text
- View/download PDF
23. Investigation of Generalized EEG Paroxysms Accompanying Focal Epilepsies
- Author
-
Atalar, Arife Çimen, primary, Vanlı-Yavuz, Ebru Nur, additional, Yılmaz, Ebru, additional, Bebek, Nerses, additional, and Baykan, Betül, additional
- Published
- 2019
- Full Text
- View/download PDF
24. Impact of seizure-related injuries on quality of life
- Author
-
Cengiz, Ozan, primary, Atalar, Arife Çimen, additional, Tekin, Betül, additional, Bebek, Nerses, additional, Baykan, Betül, additional, and Gürses, Candan, additional
- Published
- 2019
- Full Text
- View/download PDF
25. Investigation of the risk factors of transforming to chronic migraine
- Author
-
atalar, arife çimen, primary
- Published
- 2019
- Full Text
- View/download PDF
26. Auralı Migren Hastalarında Non-spesifik Serebral Ak Madde Lezyonlarının Varlığı ve İlişkili Faktörlerin Değerlendirilmesi.
- Author
-
Atalar, Arife Çimen and Yalın, Osman Özgür
- Subjects
- *
MIGRAINE diagnosis , *ALLODYNIA , *BLOOD pressure measurement , *FUNCTIONAL assessment , *HYPERTENSION , *MAGNETIC resonance imaging , *NEUROLOGIC examination , *RISK assessment , *SMOKING , *LOGISTIC regression analysis , *BODY mass index , *VISUAL analog scale , *DISEASE duration , *WHITE matter (Nerve tissue) ,MIGRAINE complications - Abstract
Aim: Cerebral white matter hyperintensities (WMLs) are known to be observed in migraine patients but there only are a handful of studies focused on WMLs in migraine with aura (MWA). In this study, we aimed to investigate the frequency of WML and demographic and environmental factors associated with WML in patients with MWA. Methods: A total of 112 patients diagnosed with migraine were enrolled. Detailed systemic and neurological examinations, blood pressure, weight and height measurements, presence of hypertension, smoking status, clinical and demographical data and visual analog scale, allodynia symptom checklist (ASC) and migraine disability assessment scale scores were recorded. The migraine groups with and without aura were compared statistically. A logistic regression analysis was performed to analyse the risk factors for the development of WMLs. Results: Supratentorial and periventricular WMLs were more frequent in patients with MWA (p=0.008). Presence of aura and longer disease duration were independent risk factors for the development of WMLs (p=0.0020 and p=0.019, respectively). Migraine attack frequency, and ASC scores were higher in patients with MWA (p=0.005, p=0.015 and p<0.001, respectively). Conclusion: Our results show a significant increase in nonspecific WMLs in patients with MWA. A longer disease duration and presence of aura are significant risk factors for development of these lesions. Our findings warrant further research to validate our result. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
27. A Case of Compartment Syndrome and Rhabdomyolysis After Alcohol Consumption
- Author
-
Atalar, Arife Çimen, primary, Söylemez, Cansu, additional, Memmedova, Fergane, additional, and Emre, Ufuk, additional
- Published
- 2018
- Full Text
- View/download PDF
28. Temporal ve ekstratemporal lob epilepsili hastalarda sempatik cilt yanıtları ve R-R interval değişkenliğinin araştırılması
- Author
-
Atalar, Arife Çimen, Savrun, Feray, Yeni, Seher Naz, and Sinir Bilimi Anabilim Dalı
- Subjects
Nöroloji ,Neurology - Abstract
Epilepsi; oldukça sık rastlanan ve dünya üzerinde yaklaşık 50 milyon insanın etkilendiği, engelliliğe neden olabilen önemli bir hastalıktır. Çeşitli klinik ve elektrofizyolojik bulgularla kendini gösteren birçok epilepsi tipi tanımlanmıştır. Çoğu epileptik nöbet interiktal, iktal veya postiktal dönemde otonom sinir sistemi fonksiyonlarında değişikliklere yol açabilmektedir. Otonom sinir sisteminin sempatik ve parasempatik bölümlerinin fonksiyonunun elektrofizyolojik olarak ortaya koyulabilmesi için günümüzde birçok yöntem bulunmasına karşılık sempatik cilt yanıtlarının incelenmesi ve R-R interval değişkenliğine bakılması en kolay, pratik ve tekrarlanabilen yöntemler olarak tercih edilmektedir.Çalışmamıza İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Nöroloji Anabilimdalı Epilepsi Polikliniğine başvuran, anamnez, detaylı nörolojik muayene, elektroensefalografik inceleme (EEG), magnetik rezonans görüntüleme (MRI) ve diğer yardımcı tanı yöntemleri kullanılarak `Epilepsi` tanısı almış olan 50 hasta ve 42 sağlıklı kontrol dahil edildi. Hasta grubu epilepsi alt tiplerine göre Temporal lob tutulumu ön planda olanlar, Jeneralize nöbetleri olanlar ve Temporal dışı (Ekstra -temporal) olarak üç ana gruba ayrıldı. Hastalara otonom sinir sistemi disfonksiyonununa dair en sık rastlanan semptomlardan oluşan bir anket formu doldurtuldu. Her hastada ortostatik hipotansiyon varlığı araştırıldı ve kaydedildi. Hasta ve kontrol gruplarına sempatik sistem fonksiyonlarının değerlendirilebilmesi amacıyla üst ekstremitede el ayası cildi üzerinden sempatik cilt yanıtlarına bakıldı. Parasempatik sistem fonksiyonlarının değerlendirilebilmesi için istirahat, derin inspiryum ve valsalva manevraları esnasında kalbin R-R intervallerinin değişkenliğine bakıldı. Çıkan sonuçlar hasta ve kontrol grupları, temporal – ektratemporal lob epilepsili gruplar, temporal-jeneralize epilepsili gruplar arasında ayrı ayrı değerlendirildi.Sonuç olarak temporal lob epilepsisi olan hastalarda terleme, sık idrara çıkma, ortostatik hipotansiyon varlığı, konstipasyon ve göz kararması gibi otonom sinir sistemi semptomları, ekstratemporal epilepsili hasta grubuna göre istatiksel olarak anlamlı derecede yüksek (p>0.05) bulundu. Hasta grubunda istirahat, derin solunum ve valsalva manevrası sırasında RR interval değişkenlik yüzdeleri kontrol grubuna göre anlamlı derecede düşük bulundu (p:0.001; p0.05). The R-R İnterval Variability percents were lower at the patient group during the resting, deep inspiration and valsalva maneveurs compared to the healthy control group (p:0.001; p
- Published
- 2017
29. Recurrent Painful Ophthalmoplegic Neuropathy: A Case Report with Five Episodes.
- Author
-
Çıplak, Ahmet Batuhan, Atalar, Arife Çimen, Yavuz, Nurettin, and Emre, Ufuk
- Subjects
- *
DIPLOPIA , *HEADACHE , *ISCHEMIA , *MIGRAINE , *CRANIAL nerves , *OCULOMOTOR paralysis , *PAIN , *STEROIDS , *VISION disorders , *DISEASE relapse , *OCULOMOTOR nerve - Abstract
Here, we describe an extraordinary case of a 38-year-old male patient with five recurrent episodes of ophthalmoplegia preceded by unilateral migraine-like headaches. He reported recurrent episodes of third cranial nerve palsy preceded by a pulsating and throbbing headache with mild photophobia for 48 hours responsive to steroid therapy, and this was his fifth attack. The clinical symptoms resolved completely after steroid therapy. After a detailed differential diagnosis was made to exclude alternative diagnoses, the patient was finally diagnosed as having recurrent painful ophthalmoplegic neuropathy (RPON). Two-thirds of RPON cases are monophasic. The underlying pathophysiologic mechanisms of RPON are still unclear, however, different hypotheses such as ischemia, demyelination, inflammation, or compression of the nerve are suggested. It is important to be alert for RPON in cases of recurrent ophthalmoplegia and make a detailed differential diagnosis [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
30. The Relationship Between 25 (OH) Vitamin D Level and the Severity of Disease and Sleep Quality in Restless Legs Syndrome.
- Author
-
Atalar, Arife Çimen
- Subjects
- *
COMPARATIVE studies , *QUESTIONNAIRES , *SLEEP , *VITAMIN D , *RESTLESS legs syndrome , *SEVERITY of illness index - Abstract
Objective: Restless legs syndrome (RLS) is a common chronic sensory-motor neurologic disease with serious disabling effects on affected individuals' physical and emotional health and quality of life. The underlying pathophysiology of the disease is not clear but iron metabolism disorders and dopaminergic dysfunction along with a genetic predisposition are blamed, and recently vitamin D deficiency was considered to play an important role in RLS. In this study, we aimed to investigate the relationship of concentrations of a vitamin D metabolite, 25 (OH) vitamin D, with RLS severity and quality of sleep. Materials and Methods: We enrolled 152 patients aged between 18 and 75 years who were referred to our general neurology outpatient clinic in Istanbul Training and Research Hospital, and diagnosed with RLS according to the International Restless Legs Syndrome Study Group diagnostic criteria, between September 2016 and September 2018. The patients were classified as the vitamin D deficiency group (<20 ng/mL, group 1) and normal vitamin D group (>20 ng/mL, group 2). Both groups were evaluated for their RLS severity index and Pittsburgh Sleep Quality Index (PQI). Both groups are compared statistically. Results: Of the 152 patients, 89 patients had low vitamin D concentrations (<20 ng/mL) (group 1) and 63 had normal vitamin D concentrations (>20 ng/ mL) (group 2). There was no significant difference in terms of age, sex, body mass index, and cigarette consumption (p>0.05). There were significant differences between the two groups in terms of upper extremity involvement, ferritin concentrations, PQI, and RLS severity scores (p<0.05). Conclusion: The present study demonstrated that patients who are vitamin D deficient might have more severe RLS symptoms and an impaired quality of sleep compared with other patients with RLS. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
31. Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
- Author
-
Cerulli Irelli, Emanuele, Cocchi, Enrico, Morano, Alessandra, Gesche, Joanna, Caraballo, Roberto H., Lattanzi, Simona, Strigaro, Gionata, Rosati, Eleonora, Catania, Cecilia, Ferlazzo, Edoardo, Casciato, Sara, Di Gennaro, Giancarlo, Pizzanelli, Chiara, Giuliano, Loretta, Viola, Veronica, Mostacci, Barbara, Pignatta, Pietro, Fortunato, Francesco, Pulitano, Patrizia, Panzini, Chiara, Gambardella, Antonio, Atalar, Arife Çimen, Labate, Angelo, Operto, Francesca Felicia, Giallonardo, Anna T., Baykan, Betül B., Beier, Christoph P., and Di Bonaventura, Carlo
- Published
- 2024
- Full Text
- View/download PDF
32. Urgent Need for ICHD Criteria for COVID-19-Related Headache: Scrutinized Classification Opens the Way for Research.
- Author
-
BAYKAN, Betül, ÖZGE, Aynur, ERTAŞ, Mustafa, ATALAR, Arife Çimen, and BOLAY, Hayrunnisa
- Subjects
COVID-19 ,EMERGENCY management ,HEADACHE ,COVID-19 pandemic - Abstract
The article discusses headache has a prevalent COVID-19 symptom and the frequent presentation has bilateral, and long-lasting with only partial or no response to analgesics. Topics include COVID-19-related headache has one of the important newly emerging forms of headache; and COVID-19-related headache, the simplistic view of a "causal" relationship with fever or respiratory symptoms has not adequate.
- Published
- 2021
- Full Text
- View/download PDF
33. Sporadic Creutzfeldt-Jakob Disease with Isolated Cerebellar Findings at Onset.
- Author
-
Yavuz, Nurettin, Erdal, Yüksel, Emre, Ufuk, Atalar, Arife Çimen, and Özgür Yalın, Osman
- Subjects
CREUTZFELDT-Jakob disease diagnosis ,CEREBELLUM diseases ,AGE factors in disease ,BASAL ganglia ,CEREBELLAR ataxia ,CREUTZFELDT-Jakob disease ,DIFFERENTIAL diagnosis ,DYSARTHRIA ,ELECTROENCEPHALOGRAPHY ,HOSPITAL admission & discharge ,HYPERTENSION ,MAGNETIC resonance imaging ,NEUROLOGIC examination ,PATIENTS ,PRIONS ,SACCADIC eye movements ,NASOENTERAL tubes ,DIAGNOSIS - Published
- 2018
- Full Text
- View/download PDF
34. Alkol Kullanımı Sonrası Gelişen Kompartman Sendromu ve Rabdomiyoliz Olgusu.
- Author
-
Atalar, Arife Çimen, Söylemez, Cansu, Memmedova, Fergane, and Emre, Ufuk
- Subjects
- *
COMPARTMENT syndrome , *ALCOHOL drinking , *RHABDOMYOLYSIS - Published
- 2018
- Full Text
- View/download PDF
35. Multiple skleroz hastalarında serum nörofilaman hafif zincir düzeylerinin hastalık aktivitesi ile ilişkisi
- Author
-
Şişman Şahin, Çağla, Atalar, Arife Çimen, and Nöroloji Anabilim Dalı
- Subjects
Nöroloji ,Neurology - Abstract
Giriş ve Amaç: Multipl Skleroz (MS), SSS'nin enflamatuar, otoimmun bir hastalığıdır. CD4 ve CD8 T hücreleri, aktive edilmiş monositler ve B hücrelerini içeren enflamasyon ile ilişkili olduğu düşünülen infiltratlar, SSS'deki lezyonlar içinde yer alır ve sonuç olarak miyelin kılıfında hasarlanmaya neden olurlar. MS'in tanı, hastalığa yatkınlık, tedavi yanıtı ve prognozunu öngörebilme adına son yıllarda birçok biyobelirteç çalışılmıştır. Bu belirteçlerin birçoğunun klinik anlamlılığı kesinleşmemiş, klinik pratikte hastalığın seyri ile anlamlı ve özgül bir ilişki elde edilememiştir. Bu biyobelirteçlerden biri nöroflamentlerdir. Biz de bu çalışmamızda MS hastalarında, atak tipi, atak sıklığı, EDSS skorları, manyetik rezonans görüntüleme ve BOS bulguları ile serum nörofilaman hafif zincir (NFL) düzeylerinin arasındaki ilişkinin değerlendirilmesini amaçladık.Gereç ve Yöntem: Çalışmaya Nöroloji Kliniğininde takipli 18-65 yaş arası Mcdonald 2017 kriterlerine göre Relapsing Remitting Multipl Skleroz (RRMS) tanısı alan, yakın zamanda atak öyküsü bulunmayan, son atağından en az 6 ay süre geçmiş olan hastalar ve sağlıklı kontrol grubu alındı. Tüm hastaların yaş, cinsiyet, hastalık süresi, atak sayısı, atak tipi (beyin sapı, duyusal, piramidal, optik nörit, spinal, serebellar), eşlik eden diğer hastalıklar, sigara öyküsü, hastalığına yönelik kullandığı ilaçlar, EDSS (expanded disability status scale) skorları, daha önce bakılmış olan laboratuar sonuçları (Tiroid fonksiyon testleri, vaskülit paneli, D vitamin düzeyi) ile VEP sonuçları kayıt edildi. Tüm hastaların daha önce çekilmiş ve sistemde kayıtlı bulunan kranial ve spinal görüntüleme bulguları değerlendirildi. Bu değerlendirmede; T2 lezyon yükü, lezyon dağılımı (supratentorial, intratentorial, spinal), kontrastlanma paterni, kara delik sayısı ve atrofi varlığı kayıt edildi. Yapılmış olan beyin omurilik sıvısı incelemesinde protein düzeyi, oligoklonal bant varlığı ve tipi, IG G indeksi kayıt edildi. Serum nörofilaman düzeyi için kan örnekleri -80 derecede uygun şartlarda saklandı ve ELİSA yöntemi ile çalışıldı.Bulgular: Hasta ve kontrol grubu karşılaştırıldığında, hasta grubunda NFL değerleri anlamlı olarak yüksek saptandı (p˂0.05). Değerlendirilen diğer parametreler arasında istatiksel anlamlı farklılık saptanmadı (p>0.05).Sonuç: Bu çalışmada, serum NFL düzeyi MS hastalarında sağlıklı kontrollerle karşılaştırıldığında anlamlı yüksek saptanmıştır. Bu durum serum NFL düzeylerinin MS hastalarında doku hasarının değerlendirilmesinde ve hastalık takibinde güvenilir bir biyomarker olarak kullanılabileceğini desteklemektedir. Purpose: Multipl Sclerosis is an inflammatory and autoimmune disease of CNS. Infiltrates that are thought to be related to inflammation, including CD4 and CD8 T cells, activated monocytes, and B cells are located within the lesions in the CNS, and as a result, they cause damage to the myelin sheath. Several biomarkers have been studied in the recent years to predict the diagnosis, disease susceptibility, treatment response and prognosis of MS. However, clinical significance of many of these biomarkers has not been confirmed, and in clinical practice neither, a significant or a specific relationship has not been concluded related to the course of the disease. One of these biomarkers are neuroflaments. In this study, we aimed to evaluate the relationship between the serum neurofilament light chain levels and attack type, attack frequency, EDSS scores, magnetic resonance imaging and CSF findings, in Multipl Sclerosis patients.Materials and Methods: Patients included in this study were selected among the ones that were admitted to Neurology Outpatient Clinic. The study group was consisted of 100 patients who were diagnosed with Relapsing Remitting Multipl Sclerosis according to Mcdonald criterias, did not have a recent attack history and have had at least 6 months passed since their last attack. 60 healthy controls with no history of any neurological diseases. Age, gender, duration of disease, number of attacks, type of attack (brainstem, sensory, pyramidal, optic neuritis, spinal, cerebellar) concomitant diseases, smoking history, drugs used for the disease, EDSS (expanded disability status scale) scores, laboratory results (Thyroid function tests, vasculitis panel, vitamin D level) and VEP results were recorded for all patients. Detailed neurological examinations were performed in both healthy controls and study groups. Previous cranial and spinal imaging findings of all patients were evaluated. In this evaluation; T2 lesion load, lesion distribution (supratentorial, intratensel, spinal), enhancement pattern, number of black holes and presence of atrophy were recorded. Protein level, oligoclonal band presence and type and IG G index were recorded in the cerebrospinal fluid examination. Blood samples were collected from the patients to study serum neurofilament levels and stored at -80 degrees until further analysis with the ELISA method.Results: Serum NFL levels between MS patients and healthy controls were compared, and serum NFL levels were found to be significantly higher in MS patients (p˂0.05). No statistically significant difference was observed in the other measured parameters (p> 0.05).Conclusion: In this study, serum NFL levels were found to be significantly higher in MS patients, compared to healthy controls. For these reasons, this study supports serum NFL value as a reliable biomarker to track tissue damage caused by disease progression in MS patients. 56
- Published
- 2020
36. Prediyaliz hastalarında uyku bozukluğunun değerlendirilmesi
- Author
-
Dartici, Zeynep Selcen, Atalar, Arife Çimen, and Nöroloji Anabilim Dalı
- Subjects
Nöroloji ,Kidney diseases ,Neurology ,Polysomnography ,Kidney failure ,Kidney failure-chronic ,Sleep disorders ,Sleep ,Dialysis - Abstract
Amaç: Uyku bozukluğu KBY'de sık görülen nörolojik komplikasyonlardan biridir. Yapılan bir çalışmada hemodiyaliz uygulanan KBY hastalarının dörtte üçünden fazlasında, bir veya daha fazla subjektif uyku yakınmasının olduğu gösterilmiştir. KBY'nin erken evrelerinde uyku bozukluğu varlığının tespit edilmesi, hastaların daha ileri dönemde karşılaşacağı fonksiyonel kaybı ve komplikasyonları en aza indirmek ve uyku bozukluğu üzerinde etkili olan parametreler ile ilişkili düzenleme yapılması konusunda fayda sağlayabilir. Biz de bu amaçla prediyaliz dönemdeki KBY hastalarında, evrelere göre uyku bozukluğunun sıklığını, uyku kalitesi ve etkileyen faktörleri, uyku bozukluğu gelişiminde etkili diğer parametreleri belirlemeyi amaçladık.Çalışma planı: Çalışmaya 75 prediyaliz dönemde takip edilen KBY hastası ile 50 gönüllü kontrol dahil edildi. Çalışmaya katılan hastaların ayrıntılı öyküleri alındı ve nörolojik muayeneleri yapıldı. Hastaların yaş, cinsiyet, vücut kitle indeksi (VKİ), hastalık evresi, eşlik eden hastalıklar ve laboratuar tetkikleri kayıt edildi. Uyku bozukluğu varlığını sorgulamak için Epworth uykululuk (EUS), Pittsburg uyku kalite indeksi (PUKİ) ölçekleri kullanıldı. Hastalarda huzursuz bacak sendromu (HBS) varlığı belirlendi, HBS olanlarda UHBSÇG skalasına göre hastalık şiddeti sorgulandı. Uyku bozukluğu saptanan hasta grubuna polisomnografi (PSG) yapıldı. Hasta ve kontrol grubundaki tüm hastalara yaşam kalite ölçeği SF-36 uygulandı.Bulgular: Hasta grubunun (Grup 1) 57'si (%76) kadın, 18'i (%24) erkek, yaş ortalaması 58±9,3, kontrol grubunun (Grup 2) ise 35'i (%70) kadın, 15'i (%30) erkek, yaş ortalamaları ise 46±15,2 idi. Hastaların %82,7'sinde diabetes mellitus (DM), %45,3'ünde hipertansiyon (HT) saptandı. GFR düzeylerine göre evre 1'de 9 (%12), evre 2'de 16 (%21,6), evre 3'de 25 (%33,3), evre 4'de 18 (%24), evre 5'de ise 7 (%9,3) hasta vardı. KBY hastalarının %42,7'sinde, kontrol grubunun %40'ında uyku bozukluğu saptandı. Uyku bozukluğu saptanan KBY hastaları arasında evre, yaş ve cinsiyet açsından istatistiksel olarak anlamlı fark saptanmadı (p>0,005). HBS, hasta grubunda 15 (%20), kontrol grubunda ise 4 hastada (%8) saptandı. Bu oran istatistiksel olarak anlamlı bulunmamakla birlikte görülme oranları bakımından literatürdeki çalışmalarla uyumlu idi. Hasta grubunda saptanan HBS'nin 9 u ağır (%12), 3'ü orta (%4) ve 3'ü hafif (%4) bulunurken kontrol grubunun 2'si hafif (%4) ve 2'si orta (%4) düzeyde saptandı. PSG yapılan 12 hastanın 1'inde (%8,3) hafif OSAS, 5'inde (%41,6) ağır OSAS, 1'inde (%8,3) REM ilişkili apne-hipopne sendromu, 4'ünde (%33,3) ise basit horlama tespit edildi. PSG yapılan HBS hastalarının NREM 1 etkinliği yüksek, NREM 2 ve 3 düşük bulundu. Hasta ve kontrol grubunu SF-36 yaşam kalite ölçeği açısından karşılaştırıldığında prediyaliz hastalarında fiziksel fonksiyon istatistiksel olarak anlamlı düşük bulunurken kontrol grubunda ise sosyal fonksiyon anlamlı derecede düşük bulundu. Sonuç: Çalışmamızda uyku bozukluğu, prediyaliz hasta grubunda kontrol grubuna göre anlamlı yüksek saptanmadı ancak hastaların yaklaşık yarısında uyku bozukluğu ve HBS ile ilgili şikayetlerin bulunması bu hastaların erken dönemde uyku kalitesi ile HBS açısından sorgulanmasının önemli olabileceğini düşündürdü.Anahtar kelimeler: Uyku bozukluğu, Prediyaliz, Kronik Böbrek Yetmezliği, Polisomnografi Objective: Sleep disorders is the most common neurological complication of CRF. In a survey-based study, more than three-quarters of hemodialysed CRF patients had one or more subjective sleep complaints. This may suggest that the presence of sleep disturbance in the early stages of CRF may minimize the functional loss and complications that patients will experience later and to regulate the parameters that are effective on sleep disturbance. For this purpose, we aimed to determine the frequency of sleep disturbance, the quality of sleep and the factors affecting sleep rate, and the effect of other related parameters in the development of sleep disorder in the prediagnosis stage of CRF patients.Method: 75 predialysis patients and 50 healty volunters as the control group were included in the study. A detailed anamnesis was obtained from each participating patietns and all underwent a neurological examination. Patient's age, cender, body mass index (BMI), stage of the disease, comorbidities and laboratory examinations were recorded. Epworth sleepiness scale (EUS), Pittsburgh sleep quality index (PSQI) scales were used to investigate the presence of sleep disorder. The presence of restless leg syndrome (RLS) was questioned in patients, the severity of the disease was questioned in patients with RLS according to IRLSSG scale. Polysomnography (PSG) was performed in the patient group who had sleep disorder. Quality of life SF-36 was applied to all patients in the patient and control groups.Results: Of the 75 patients included in the study, 57 (76%) were female and 18 (24%) were male. The mean age was 58 ± 9.3 years. Of the 45 healthy volunteers included in the control group, 35 (70%) were female and 15 (30%) were male and the mean age was 46 ± 15.2. The most common concomitant diseases were 82.7% diabetes mellitus and 45.3% hypertension. According to GFR levels, 9 (12%) in stage 1, 16 (21.6%) in stage 2, 25 (%33.3) in stage 3, 18 (%24) in stage 4, stage 5 There were 7 (%9.3) patients. %42.7 of the patients with CRF and %40 of the control group had sleep disorders. RLS was detected in 15 patients (20%) in the CRF group and 4 patients (8%) in the control group. Although this rate was not statistically significant, it was found to be consistent with the literature in terms of incidence rates. Of the RLS detected in CRF patients, 9 were severe (%12), 3 were moderate (%4), and 3 were mild (%4). Of the 12 patients, 1 (%12,3) had mild OSAS, 5 (%41,6) had severe OSAS, 1 (%8,3) had REM-related apnea-hypopnea syndrome, 4 (% 33,3) found simple snoring. The results of 1 patient could not be evaluated because sleep efficiency was low. Of the 12 patients who underwent PSG, 1 patients (%8,3) had mild OSAS, 5 patient (%41,6) had severe OSAS, 1 patient (%8,3) had REM related apnea-hypopnea syndrome, and 4 patient (%33,3) found simple snoring. In patients with RLS, NREM 1 activity was high and NREM 2 and 3 were low. In the comparison of CRF patients and control group SF-36 quality of life scale, physical function was significantly lower in CRF patients and social function was significantly lower in control group.Conclusion: In our study, sleep disturbance in predialysis patients was not high compared to the control group. The fact that about half of the patients had complaints of sleep disorder and HBS suggests that it may be important to question these patients in terms of sleep quality and HBS in the early period.Key words: Sleep Disorder, Predialysis, Chronic Renal Failure, Polysomnography 108
- Published
- 2019
37. Living with Burden of Migraine: The Analysis of "My Migraine Voice" Survey Results in Turkey.
- Author
-
Atalar AÇ, Bozkurt M, Çalişkan Z, Vo P, Ertaş M, and Baykan B
- Abstract
Introduction: Migraine is a common, chronic neurologic disease which causes serious social and economical disability at both the individual and the community level. The aim of this study was to interpret the data for Turkey from "My Migraine Voice," an online survey of individuals suffering from frequent migraine attacks (≥4 days/month with migraine headaches) who had not benefited from existing prophylactic therapies, conducted in 31 countries to investigate the burden of migraine for the individual and the society., Methods: Based on a set of predetermined criteria (90% of the patients must have used prophylactic therapy, and 80% of them must have needed to change therapy), patients who had ≥ 4 days in a month with migraine headache in the past 3 months were asked to take an online survey of 88 questions. The study included questions aimed at determining the burden of disease during not only the headache phase, but also the prodrome and postdrome phases, as well as a questionnaire for determining the Reduction of Overall Activity and Productivity at Work ((WPAI: GH)., Results: A total of 237 patients from Turkey were included in the study. 62% of the patients stated that they were severely or very severely disabled in their daily activities during the headache phase of migraine, and 31% and 34% of the patients reported that they were disabled during the prodrome and postdrome phases, respectively. 28% of the patients stated they had been receiving prophylactic therapy for more than 2 years, and only 84% of these patients reported complete or partial satisfaction with their current therapies. This value was as low as ~70% in patients in whom 2 or more previous drug treatments or therapies had failed. Actively-working patients reported that they had lost 21% of their time at work due to migraine, and the overall loss of workforce was 67%., Conclusion: This study showed that migraine can cause disability in an individual's private and professional lives during every stage of migraine, including the prodrome and postdrome phases. This finding will be important for designing future treatments aimed at enhancing the quality of life and productivity of patients who cannot adequately benefit from existing therapies., Competing Interests: Conflict of Interest: Manal Bozkurt, Zeynep Çalışkan and Pamela Vo are the employees of Novartis., (Copyright: © 2021 Turkish Neuropsychiatric Society.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.